Autopsy report · NCT01880307

Infliximab Top-down in Pediatric Crohn

“Not enough study subjects”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months after it had already started.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Erasmus Medical Center

Sponsor type

University, hospital or other

Conditions

Crohn's Disease

Interventions

Azathioprine; Infliximab; Prednisolon

Participants

13

Sites

2

Countries

Italy, Netherlands

Trials that died the same way

• Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.
  “Not enough subjects.” (82% match in meaning)
• ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis
  “Not able to find enough subjects” (80% match in meaning)
• Liposomal Bupivacaine in Ambulatory Hand Surgery
  “Inadequate number of subjects meet study criteria” (79% match in meaning)
• Safety Study of Inhaled Saline in Acute Lung Injury
  “difficult getting subjects” (78% match in meaning)
• Acitretin Plasma Levels Under Hemodialysis
  “lack of subjects” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.